IboMexico Blog

Cardiac Risk in Ibogaine Research: What Monitoring Can—and Cannot—Show

IboMexico Team — Mon, 26 Oct 2026 16:03:00 GMT

Ibogaine research has documented changes in the heart's electrical timing, even in selected, monitored participants. Those findings make cardiac risk important to study; they do not establish a dependable event rate or show that screening removes the hazard.

Ibogaine Research Transparency: Why Trial Registration Is Not a Result

IboMexico Team — Fri, 23 Oct 2026 16:05:00 GMT

A study listing can make research more transparent without proving that an intervention works. Understanding the difference between a registered plan, reported results, and regulatory approval is especially important while ibogaine's evidence and safety questions remain unresolved.

Informed Consent in Ibogaine Research: More Than a Signature

IboMexico Team — Mon, 19 Oct 2026 16:05:38 GMT

Informed consent is a continuing exchange about research, risks, and choices—not evidence that an investigational product works. The FDA's current ibogaine discussion makes that distinction especially important.

A 2026 Alcohol-Use Pilot Highlights the Limits of Ibogaine Evidence

IboMexico Team — Thu, 15 Oct 2026 21:33:09 GMT

An accepted 2026 pilot paper describes cardiac changes in a small ibogaine study involving adults with alcohol use disorder. Its open-label design, incomplete assessments, and self-reported outcomes limit conclusions about efficacy and safety.

Don’t Let the Stigma Stop You: What People Get Wrong About Ibogaine

IboMexico Team — Tue, 28 Jul 2026 16:00:00 GMT

Ibogaine carries the weight of drug stigma, Schedule I classification, and cultural unfamiliarity. But the evidence — and the experience of thousands of people who have been through it — tells a more nuanced story.

Opiates, Trauma, and Burnout: Who Benefits Most from Ibogaine?

IboMexico Team — Mon, 27 Jul 2026 16:00:00 GMT

Understanding who responds best to ibogaine treatment helps set realistic expectations and improves outcomes. The research and clinical experience point to several distinct profiles where ibogaine’s effects are most pronounced.

The Neuroprotective Benefits of Ibogaine: Beyond Addiction Recovery

IboMexico Team — Fri, 24 Jul 2026 16:00:00 GMT

GDNF upregulation, BDNF release, neuroplasticity, and anti-inflammatory effects — ibogaine’s neuroprotective profile is attracting serious attention from researchers working on some of the hardest problems in neuroscience.

Breaking the Cycle: How Ibogaine Can Help You Overcome Addiction

IboMexico Team — Thu, 23 Jul 2026 16:00:00 GMT

For many people, ibogaine does something that years of conventional treatment could not: it interrupts the compulsive loop of addiction at a neurological level, buying a window of clarity that — with the right support — can become lasting change.

The Medical Difference Between Iboga and Ibogaine HCL

IboMexico Team — Wed, 22 Jul 2026 16:00:00 GMT

The difference between whole iboga root bark, total alkaloid extract, and purified ibogaine HCL is more than a matter of chemistry — it affects dosing, duration, safety profile, and therapeutic outcome.

Medical Ibogaine Detox: What to Look for in a Clinical Setting

IboMexico Team — Tue, 21 Jul 2026 16:00:00 GMT

Ibogaine is a powerful alkaloid that demands rigorous medical oversight. Knowing what to look for in a clinical setting can be the difference between a transformative experience and a dangerous one.

What Is Ibogaine? The Complete Guide to the Reset Medicine

IboMexico Team — Thu, 25 Jun 2026 00:00:00 GMT

Ibogaine is a naturally occurring psychoactive compound derived from the root bark of the Tabernanthe iboga plant, native to Central and West Africa. For centuries, the Bwiti people of Gabon have used it in sacred initiation ceremonies. Today, it sits at the center of one of the most promising — and controversial — frontiers in addiction medicine.

The Stanford Study That Changed Everything

IboMexico Team — Thu, 18 Jun 2026 00:00:00 GMT

When Stanford Medicine published its study on ibogaine treatment for veterans with traumatic brain injuries in January 2024, the findings were so striking that they prompted immediate congressional attention. The study documented dramatic improvements in PTSD, depression, and cognitive function — changes that persisted months after a single treatment session.

How to Choose an Ibogaine Clinic in Mexico

IboMexico Team — Wed, 10 Jun 2026 00:00:00 GMT

Choosing an ibogaine clinic is one of the most consequential decisions you will make. The difference between a well-run medical facility and an unmonitored retreat can, in rare cases, be the difference between transformation and tragedy. Here is what to look for.

Mexico's Quiet Answer to the Opioid Crisis

IboMexico Team — Wed, 03 Jun 2026 00:00:00 GMT

In Tijuana, a short drive from the San Diego border crossing, a cluster of clinics quietly treats thousands of Americans each year for opioid addiction. They use a substance that is illegal in the United States but unregulated in Mexico — ibogaine — and their patients report outcomes that conventional treatment rarely achieves.

The Ibogaine Experience: An Hour-by-Hour Guide

IboMexico Team — Fri, 22 May 2026 00:00:00 GMT

The ibogaine experience is unlike any other psychedelic. It is longer, more physically intense, and more emotionally demanding than psilocybin or MDMA. Understanding what to expect — hour by hour — can help you prepare mentally and physically for the journey.

The Ancient Roots: Ibogaine and the Bwiti Tradition

IboMexico Team — Fri, 08 May 2026 00:00:00 GMT

In the forests of Gabon and Cameroon, the Bwiti people have been using the root bark of the Tabernanthe iboga plant for centuries in sacred initiation ceremonies. To the Bwiti, iboga is not a drug — it is a sacrament, a teacher, and a path to the ancestors.

Ibogaine vs. Ketamine: Which Psychedelic Therapy Is Right for You?

IboMexico Team — Tue, 28 Apr 2026 00:00:00 GMT

Ketamine clinics have proliferated across the United States. Ibogaine treatment centers cluster across the border in Mexico. Both are being discussed as breakthroughs in mental health and addiction treatment — but they work very differently, cost very differently, and are suited to very different patients.

The Legal Landscape: Ibogaine in Mexico and the US in 2026

IboMexico Team — Sun, 05 Apr 2026 00:00:00 GMT

Ibogaine occupies a peculiar legal position in North America. In the United States, it is a Schedule I controlled substance — the same category as heroin — making clinical use impossible. In Mexico, it exists in a regulatory gray zone that has enabled a thriving treatment industry. Understanding this landscape is essential for anyone considering treatment.

Integration: The Work That Happens After the Session

IboMexico Team — Thu, 12 Mar 2026 00:00:00 GMT

The ibogaine session is not the treatment. It is the beginning of the treatment. The neuroplastic window that ibogaine opens — a period of unusual cognitive flexibility and emotional openness — lasts roughly 2–4 weeks. What you do with that window determines how much of the session's potential you actually realize.

The Complete Cost Guide to Ibogaine Treatment in Mexico (2026)

IboMexico Team — Fri, 20 Feb 2026 00:00:00 GMT

Ibogaine treatment in Mexico is not cheap. Prices range from $4,500 to $18,000 depending on the clinic, program length, and level of medical oversight. Understanding what drives these costs — and what you should expect to get at each price point — is essential for making an informed decision.